853 KB
ALEMBIC PHARMA INVESTORS PRESENTATION Q3
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
APLLTD Share Price Discussion
Alembic Pharmaceuticals Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
APLLTD Long Term Analysts Rating
- ★★
- ★★
- ★★
- ★★
- ★★
3.7/5 (7 Ratings)
APLLTD Share Price *
590 -9.6 (-1.6%)
* (quote may be delayed)
Find answers to all your questions on live APLLTD message board: Is APLLTD buy or sell? Should I buy APLLTD shares? Why are APLLTD shares falling? Should I invest in APLLTD stock?
You can also check APLLTD share price target recommended by brokerages.
APLLTD Discussion Forum
@ravikanthchopperla • Reputation: 10,701
Alembic Pharmaceuticals received the U.S. Food & Drug Administration (USFDA) Final Approval for Travoprost Ophthalmic Solution USP, 0.004%. The stock was up 1%.
Like
reply
Reply
@invictotrader • Reputation: 2,053
Alembic Pharmaceuticals gets USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004%
Like
reply
Reply
@ravikanthchopperla • Reputation: 10,701
Alembic Pharmaceuticals’s subsidiary, Aleor Dermaceuticals, has received Establishment Inspection Report (EIR) from the USFDA for the inspection carried out at Karakhadi, Gujarat, during September. The stock was up 0.8%.
1
reply
Reply
@ravikanthchopperla • Reputation: 10,701
Alembic Pharmaceuticals Gets USFDA Approval For Silodosin Capsules
Like
reply
Reply
@databot • Reputation: 1,317
YES Securities Recommendation on APLLTD
Date: 24-Oct-19
Broker: YES Securities
Price @ Call: 545.77
Target: 600
Recommendation: BUY
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma rises 2% on USFDA approval for Desonide Ointment
Desonide Ointment has an estimated market size of USD 13 million for 12 months ending December 2018, according to IQVIA.
Desonide Ointment has an estimated market size of USD 13 million for 12 months ending December 2018, according to IQVIA.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharmaceuticals rises 3% after JV drug gets US approval
The company's joint venture Aleor Dermaceuticals has got USFDA approval for a spray to treat plaque psoriasis.
The company's joint venture Aleor Dermaceuticals has got USFDA approval for a spray to treat plaque psoriasis.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharmaceuticals gains 3% on zero observations from USFDA
USFDA inspected Vadodara facility between August 12, 2019 to August 20, 2019 for Bioequivalence Bioanalytical and Bioequivalence Clinical.
USFDA inspected Vadodara facility between August 12, 2019 to August 20, 2019 for Bioequivalence Bioanalytical and Bioequivalence Clinical.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Stocks in the news: SPARC, SpiceJet, Alembic Pharma, Dr Reddys Labs, United Spirits, Deepak Nitrite
Alembic Pharma | Dr Reddy's Labs | United Spirits | HDIL | Deepak Nitrite | IOL Chemicals and Freshtrop Fruits are stocks which are in the news today.
Alembic Pharma | Dr Reddy's Labs | United Spirits | HDIL | Deepak Nitrite | IOL Chemicals and Freshtrop Fruits are stocks which are in the news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma gets USFDA nod for cholesterol lowering drug
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Fenofibrate tablets in the strengths of 48 mg and 145 mg, Alembic Pharmaceuticals said in a BSE filing.
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Fenofibrate tablets in the strengths of 48 mg and 145 mg, Alembic Pharmaceuticals said in a BSE filing.
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
Hold Alembic Pharma; target of Rs 540: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 540 in its research report dated July 30, 2019.
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 540 in its research report dated July 30, 2019.
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 1,933
An evening walk down D-St: Nearly 400 stocks hit 52-week low on a volatile day
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharmaceuticals gains 2% on USFDA approval for Dapagliflozin tablets
Like
reply
Reply
@tmtview • Reputation: 820
(TMT) ALEMBIC PAHRMA LTD. (526.80): TRADED ABOVE RESISTANCE LINE , ENTER AT CMP AND ADD MORE ABOVE 540 STRONG SUPPORT ZONE 505-495 AREA POSSIBLE MOVE 580-630+
Like
reply
Reply (1)
Latest replies
542 CLOSE TODAY
@newsbot • Reputation: 1,933
An evening walk down D-Street: Bulls push Nifty above 11,900; all eyes on Budget now
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma climbs 6% on USFDA nod for Febuxostat tablets
Like
reply
Reply
@newsbot • Reputation: 1,933
IFCI, Cox & Kings, Radico Khaitan among 10 stocks which moved the most last week
Like
reply
Reply
@newsbot • Reputation: 1,933
An evening walk down D-Street: NITI Aayog's aggressive EV push drags auto stocks
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma gains 3% on USFDA nod for Bromfenac Ophthalmic solution
Like
reply
Reply
@newsbot • Reputation: 1,933
Stocks in the news: Wipro, Indiabulls Real, Just Dial, Cyient, CreditAccess, JSW Steel
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma gets USFDA nod for overactive bladder treatment drug
Like
reply
Reply
@neeraj • Reputation: 1,396
Free call - Start watching - APLLTD now at 557. it can run more from here.
Keep stoploss if you trading in this call
#equity #intraday #nse #nifty #nifty50 #trading #traders #trader #stockmark
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma gains 1% on USFDA nod for Teriflunomide tablets that treat sclerosis
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma gains as co gets USFDA approval for Tadalafil tablets
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma gets USFDA nod for conjunctivitis treatment drug
Like
reply
Reply
@newsbot • Reputation: 1,933
Volume shockers: Alembic Pharma, KPIT Tech among 5 stocks that are moving the most
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharmaceuticals rises 3% on USFDA approval for Fenofibrate tablets
Like
reply
Reply
@newsbot • Reputation: 1,933
Stocks in the news: Hindalco, Axis Bank, Max India, Alembic Pharma, PI Industries, Edelweiss
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma Q3 PAT seen up 7.7% YoY to Rs. 140.6 cr: ICICI Direct
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma gets USFDA nod for Parkinson's treatment drug
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma gains 1% on USFDA approval for Parkinson's drug
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharma gains 4% after successful inspection by USFDA
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharmaceuticals gets USFDA nod for ophthalmic solution
Like
reply
Reply
@newsbot • Reputation: 1,933
Alembic Pharmaceuticals gains on USFDA approval; NCD Committee meet on Dec 14
Like
reply
Reply
- NewsBotOct 24 4:23 PMAlembic Pharma rises 2% on USFDA approval for Desonide OintmentMoneycontrolNewsBotOct 4 5:08 PMAlembic Pharmaceuticals rises 3% after JV drug gets US approvalMoneycontrolNewsBotAug 21 4:13 PMAlembic Pharmaceuticals gains 3% on zero observations from USFDAMoneycontrolNewsBotAug 21 3:29 PMStocks in the news: SPARC, SpiceJet, Alembic Pharma, Dr Reddys Labs, United Spirits, Deepak NitriteMoneycontrolNewsBotAug 13 5:18 PMAlembic Pharma gets USFDA nod for cholesterol lowering drugmoneycontrol.comNewsBotJul 31 9:58 PMHold Alembic Pharma; target of Rs 540: ICICI Directmoneycontrol.comNewsBotJul 23 10:18 PMAn evening walk down D-St: Nearly 400 stocks hit 52-week low on a volatile dayNewsBotJul 23 4:33 PMAlembic Pharmaceuticals gains 2% on USFDA approval for Dapagliflozin tabletsNewsBotJul 2 10:43 PMAn evening walk down D-Street: Bulls push Nifty above 11,900; all eyes on Budget nowNewsBotJul 2 4:08 PMAlembic Pharma climbs 6% on USFDA nod for Febuxostat tablets
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.